Impact on survival of addition of etoposide to primary chemotherapy in diffuse large B-cell lymphoma: a Swedish Lymphoma Registry study.

Wästerlid, Tove; Hartman, Linda; Székely, Elisabeth; Jerkeman, Mats

Wästerlid, Tove; Hartman, Linda; Székely, Elisabeth; Jerkeman, Mats.

Affiliation

Wästerlid T; Lund University, Department of Clinical Sciences Lund, Department of Oncology, Lund, Sweden.
Hartman L; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Sweden.
Székely E; Regional Cancer Centre South, Lund, Sweden.
Jerkeman M; Lund University, Department of Clinical Sciences Lund, Department of Oncology, Lund, Sweden.

Hematol Oncol ; 35(2): 151-157, 2017 Jun.

Article in En | MEDLINE | ID: mdl-26369736

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Lymphoma, Large B-Cell, Diffuse/drug therapy; Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived/administration & dosage; Antineoplastic Combined Chemotherapy Protocols/administration & dosage; Cyclophosphamide/administration & dosage; Doxorubicin/administration & dosage; Etoposide/administration & dosage; Female; Humans; Lymphoma, Large B-Cell, Diffuse/mortality; Male; Middle Aged; Prednisolone/administration & dosage; Prednisone/administration & dosage; Registries; Rituximab; Vincristine/administration & dosage

Key words

chemotherapy regimen; diffuse large B-cell lymphoma; dose density; etoposide

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Lymphoma, Large B-Cell, Diffuse Type of study: Clinical_trials / Prognostic_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Hematol Oncol Year: 2017 Type: Article Affiliation country: Sweden

Fulltext

XML

PubMed Links

Search on Google